Skip to content

    Kiniksa Pharmaceuticals International (KNSA) stock price & financials

    View KNSA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+131.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $108.63M
    $112.21M
    $122.54M
    $137.78M
    $156.80M
    +44.3%
    $180.85M
    +61.2%
    $202.13M
    +65.0%
    $214.27M
    +55.5%
    Strengthening
    Operating Profit
    -$117.0K
    -$9.66M
    -$19.30M
    $13.27M
    $20.16M
    $24.02M
    $19.77M
    $29.27M
    +120.5%
    Strengthening
    Net Profit
    -$3.91M
    -$12.69M
    -$8.89M
    $8.54M
    $17.83M
    $18.43M
    $14.20M
    $22.59M
    +164.6%
    Strengthening
    EPS
    $-0.06
    $-0.18
    $0.12
    $0.24
    $0.25
    $0.30
    +150.0%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    $2.30M
    -$7.20M
    -$16.98M
    $15.56M
    $22.88M
    +892.9%
    $27.16M
    $23.27M
    $32.68M
    +110.0%
    Strengthening
    MarginsOPM
    -0.1%
    -8.6%
    -15.8%
    9.6%
    12.9%
    13.3%
    9.8%
    13.7%
    +41.8%
    Strengthening
    Tax
    269.6%
    -76.3%
    47.6%
    45.1%
    22.1%
    -91.8%
    32.1%
    39.0%
    -18.2%
    30.9%
    -31.6%
    Weakening
    ReturnsROIC
    0.9%
    2.9%
    2.0%
    -1.9%
    -4.1%
    -556.3%
    -4.2%
    -245.2%
    -3.2%
    -259.8%
    -5.1%
    -164.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$71.98M$46.93M$114.04M$122.47M$122.72M$107.95M$183.58M$165.60M$189.95M
    Short-Term Investments
    Total Current Assets$313.75M$241.63M$333.25M$196.45M$243.06M$276.30M$331.80M$527.18M$594.17M
    Net PP&E$6.36M$8.32M$10.62M$8.38M$7.04M$12.66M$11.04M$11.75M$11.32M
    Goodwill
    Intangibles$0$19.25M$18.25M$17.25M$16.25M$15.25M$15.00M
    Total Assets$321.96M$254.53M$349.46M$232.80M$459.67M$526.32M$580.55M$763.63M$825.28M
    LiabilitiesTotal Current Liabilities$42.55M$27.83M$31.85M$44.82M$47.07M$63.67M$100.62M$139.18M$156.61M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$955.0K$4.88M$2.67M$2.62M$10.01M$7.86M$6.51M$5.86M
    Total Liabilities$42.70M$29.11M$37.53M$47.76M$63.52M$87.48M$142.12M$196.03M$219.59M
    EquityCommon Stock & APIC
    Retained Earnings-$194.22M-$356.09M-$517.47M-$675.40M-$492.03M-$477.95M-$521.14M-$462.14M-$439.55M
    Total Equity$279.27M$225.42M$311.94M$185.04M$396.15M$438.84M$438.44M$567.61M$605.69M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$81.01M-$158.37M-$136.53M-$126.30M$5.81M$13.30M$25.69M$137.99M$165.86M
    Cash from Investing-$239.20M$49.21M-$23.44M$128.63M-$8.08M-$29.56M$37.67M-$188.99M-$169.37M
    Cash from Financing$346.74M$84.11M$227.09M$5.88M$2.52M$1.50M$12.27M$33.02M$36.33M
    SummaryCapital Expenditure-$5.29M-$3.20M-$283.0K-$415.0K-$105.0K-$130.0K-$277.0K-$1.57M-$1.63M
    Free Cash Flow-$86.30M-$161.57M-$136.81M-$126.71M$5.70M$13.17M$25.41M$136.42M$164.23M
    FCF Margin-328.7%2.6%4.9%6.0%20.1%21.8%

    Ratios